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D CHRONIC CRITICAL LIMB ISCHAEMIA
01
DEFINITION AND NOMENCLATURE FOR
CHRONIC CRITICAL LIMB ISCHAEMIA
01.1
Nomenclature
Clinicians generally agree on the type of patient
described as having chronic critical limb ischaemia
(chronic CLI), but attempts at a precise definition have
been problematic. The clinical concept is of patients
with typical chronic ischaemic rest pain or patients
with ischemic skin lesions, either ulcers or gangrene.
This clinical description easily distinguishes patients
with chronic CLI from those with intermittent claudi-
cation alone, however severe the claudication may be
(see also B 1.1.1, Patient Characteristics in Intermittent
Claudication, p 547), or patients with a sudden onset
of ischaemia (see C 1.1, Definition of Acute Limb
Ischaemia, pS115). The term CLl should only be used
in relation to patients with chronic ischaernic disease.
01.1.1
Historical Background
In 1954, Fontaine et all proposed a simple clinical clas-
sification of patients with ischaernic rest pain but no
skin lesions as belonging to stage III PAD and patients
who had skin lesions as stage IV PAD. Chronic critical
limb ischaemia (CLl) can be used simply as a collective
term for these patients. CLI is also equivalent to the
clinical description of grades II and III, which includes
categories 4, 5, and 6 of the North American recom-
mendations for reporting standards.t The clinical dis-
tinction from claudicants has a pathological parallel;
in claudicants, the tissue ischaemia is in the muscle
and is intermittent. Patients with intermittent claudi-
cation have no circulatory deficit or symptoms except
when they exercise. By contrast, patients with ulcers
or gangrene have an impaired circulation to the skin
most of the time . Patients without ulcers or gangrene
may only experience rest pain when their leg is hori-
zontal and the perfusion pressure is decreased. The
problem with this simple classification is that the term
chronic CLl (or Fontaine III and IV) includes a whole
spectrum of patients, from those with mild, easily con-
trolled rest pain to patients with extensive gangrene of
the foot, in whom there is no alternative to an early
major amputation. However, intermittent claudication
also encompasses a wide spectrum of disability.
Attempts have been made to subdivide the broad
category of chronic CLI. In 1981, an ad hoc working
party met .and published a definition of "Critical
Ischaemia" in the British [ournal of Surgenj» The def-
inition is based on the concept of "limb-threatening
ischaemia," a term used to describe ischaemia of
such severity that in the absence of a successful
revascularisation the leg will require a major ampu-
tation. The term limb salvage was added to describe
this indication for surgery, and the definition of crit-
icallimb ischaemia then aims at defining this indica-
tion for limb salvage surgery. The 1981 definition
included an absolute ankle systolic Doppler pres-
sure of less than 40 mm Hg in patients with chronic
ischemic rest pain and an ankle systolic pressure less
than 60 mm Hg in patients with ulcers or gangrene.
The authors excluded patients with diabetes from
the definition and did not offer any alternative defi-
nition to be applied to such patients. On the basis of
a 'l-year follow-up of such patients, one of the
authors of the original recommendation suggested
omitting any pressure limit for patients with ulcers
or gangrene, but retained the 40-mm Hg pressure
limits for patients with rest pain.'
Meanwhile, in 1986, a committee on reporting stan-
dards of the Society for Vascular Surgery (SVS) and
the North American Chapter of the International
Society of Cardiovascular Surgery (ISCVS) made a rec-
ommendation for clinical categories of chronic limb
ischaemia. This had the same resting ankle pressure
limit (40 mm Hg for rest pain, 60 mm Hg for nonheal-
ing ulcers) but added the possibility of measuring the
toe pressure, which had to be below 30 mm Hg or "a
barely pulsatile ankle or metatarsal plethysmographic
tracing." For patients with ulcers or gangrene, the
alternative of a toe pressure below 40 mm Hg was
included in the definition.s Next, a European
Consensus Document on Chronic Critical Leg
Ischaemia continued the same trend, that is, trying to
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define a group of patients who would inevitably
require amputation in the absence of successful revas-
cularisation. In that particular document, the same
pressure limits of 50 mm Hg at the ankle or 30 mm Hg
at the toe were suggested for all patients with rest
pain, ulcers, or gangrcne,e
More recently, Wolfe and Wyatt? analysed the litera-
ture and suggested that a low-risk and a high-risk
group should be identified within patients with severe
leg ischaemia. They attempted to calculate the major
amputation rate at 1 year of patients in these two
groups treated conservatively (nonsurgically). The
low-risk group contained only patients with rest pain
alone and an ankle pressure above 40 mm Hg. At 1
year, 73% of patients in this group lost their leg or died
if treated conservatively. The high-risk group con-
tained patients with rest pain and an ankle pressure
less than 40 mm Hg and all patients who had ulcers or
gangrene. Ninety-five percent of these patients treated
conservatively required an amputation or died within
1 year. They concluded that "Reconstructive surgery
should be viewed from the following, more realistic,
perspective. For patients with rest pain (and/or ankle
pressure over 40 mm Hg), 100% cumulative patency is
equivalent to 64% resolution of symptoms at one year
as the rest pain in some (9%) may have improved
without treatment. For higher risk patients (tissue loss
and/or ankle pressure less than 40 mm Hg) 100%
cumulative patency is equivalent to 93% limb salvage
at one year." Wolfe and Wyatt then went on to recom-
mend that future reports should identify these two
groups separately? Their analysis may be unreliable,
because most of the literature on which the conclu-
sions were based do not quote Doppler pressure,
many include patients with intermittent claudication,
and many are postoperative series.
D 1.1.2
Problems With Recent Definitions of Chronic Critical
Limb Ischaemia
At least four problems arise with all of these post-
Fontaine definitions if they are applied to the clinical
management of individual patients. The first is the
impossibility of defining prospectively a group of
patients who wiII inevitably require a major amputa-
tion in the absence of successful revascularisation
unless the criteria are so severe that extremely few
patients would qualify. Severe, exclusive criteria may
be justified in reporting practices or trial protocols for
the purpose of assuring that all limbs are truly at risk,
but these criteria are of limited use for clinical man-
agement. As pointed out in the most recent
"Recommended Standards for Reports Dealing With
Lower Extremity Ischaemia" from the SVS and ISCVS,
the term limb salvage is a misnomer and probably is
best abandoned.'
The second problem with previous definitions
attempting to identify a specific subgroup of patients
within the CLI group is that the division between sub-
groups is arbitrary and therefore of little utility in the
management of individual patients. Indeed, the stim-
ulus for all of these more recent definitions has been
the issue of reporting large series of patients with rest
pain or nonhealing ulcers treated in trials of a particu-
lar form of surgery or pharmacotherapy. A more or
less arbitrary division does not matter in that context.
Third, all post-Fontaine definitions of CLI using arbi-
trary pressure limits exclude some patients with rest
pain or possibly even ulcers, leaving them in limbo;
they are clearly not patients with intermittent claudi-
cation, but nor are they patients with CLI by these def-
initions. Fourth, it is simply not known what would
happen to a patient with severe leg ischaemia in the
absence of treatment. Most information looks at
patients treated "conservatively," but they are clearly
a selected subgroup in no way representative of all
patients with rest pain, ulcers, or gangrene. They are
usually patients in whom a revascularisation proce-
dure is not possible or has failed already.
D 1.1.3
Suggested Approach to Resolving the Problem
The current confusion may be partly clarified by
clearly distinguishing between terms used to describe
individual patients and their clinical management
from much more precise definitions used to describe
a circumscribed group of patients in a clinical trial.
The former needs to be inclusive, and the latter can be
exclusive. A clinical definition must include all indi-
vidual patients who may present to a clinician, but a
definition of a particular group of patients for trial
protocol purposes can afford to exclude some
patients. Therefore, for everyday clinical practice, it is
not helpful to refine the original Fontaine classifica-
tion.
The general inclusive term chronic critical limb
ischaemia (Cl.I) is proposed to include patients with
ischemic rest pain (Fontaine stage III) and patients
with ischemic ulcers or gangrene (Fontaine stage IV).
PAD has to be proven objectively, normally by ABPI or
toe Doppler pressures. This term inevitably includes
patients at very different levels of risk to their leg, just
as the term intermittent claudicant includes patients
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with very different claudication distances. It is
proposed that the term CLI should be based solely on
clinical presentation of the patient and evidence that
the rest pain, ulcers, or gangrene are predominantly
caused by PAD. The evidence for PAD could equally
well come from plethysmography, transcutaneous
partial pressure of oxygen (TCP02) measurement,
duplex, or angiography, and these are discussed in
more detail in Investigations (see D 2.2, P 5152). The
term CLIis used in this clinical sense in this TA5C doc-
ument. The issue of defining a circumscribed/homo-
genous group of patients, with an overall predictable
outcome, for clinical trial purposes, is discussed in
Clinical Trial Issues in Critical Limb Ischaemia, D6,
p 5237 (see Recommendation 74).
Recommendation 73: Clinical definition of critical
limb ischaemia
The term critical limb ischaemia should be used for
all patients with chronic ischemic rest pain, ulcers,
or gangrene attributable to objectively proven arte-
rial occlusive disease. The term critical limb
ischaemia implies chronicity and is to be distin-
guished from acute limb ischaemia.
Recommendation 74:Trials and reporting standards
definition of critical limb ischaemia
A relatively inclusive entry criterion is favoured,
the aim being to ensure that the ulceration, gan-
grene, or rest pain is indeed caused by peripheral
arterial disease and that most would be expected
to require a major amputation within the next
6 months to a year in the absence of a significant
haemodynamic improvement. To achieve this, it is
suggested to use absolute pressures of either
ankle pressure < 50-70 mm Hg or
reduced toe pressure «30-50 mm Hg) or
reduced TCP02 «30-50 mm Hg)
The features that make a particular patient with CLI
more or less at risk are clearly described in the epi-
demiological section (see A 2.7, Fate of Patients With
Critical Limb Ischaemia, p 521). For instance, legs with
rest pain are in general at less risk than legs with
ulcers or gangrene; legs with a low ankle systolic pres-
sure are at greater risk than legs with a higher ankle
systolic pressure.
The latest recommended set of standards for reports
dealing with low-extremity ischaemia from the 5V5
and the I5CV5 also raises a completely new issue. It
identifies a particular subgroup of patients with PAD
who do not fall within the definitions of either claudi-
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cation or chronic CLI. These patients have severe PAD
with low perfusion pressures and low ankle systolic
pressures, but are completely asymptomatic. They are
sedentary and therefore do not claudicate, and if they
have managed to avoid trauma, they may not have
ulcers or gangrene. In this asymptomatic no-man's-
land, they are nevertheless very vulnerable, a small
knock away from CLI. The term chronic subcritical
ischaemia is suggested for these patients by the
5V5/I5CV5 document. 2 Confusion may arise because
of an alternative use of the term subcriticat ischaemia
by some European authors to describe patients with
ischemic rest pain but a comparatively high ankle
pressure, say above 40 to 60 mm Hg. These patients
are probably at a much lesser risk of requiring a major
amputation in the absence of successful revascularisa-
tion than patients with rest pain and lower pressures
or patients with ischemic ulcers and gangrene.
Recognition of this distinction is particularly impor-
tant in the clinical trial and reporting context.
Critical Issue 27: High-risk patients not covered by
current criteria for critical limb ischaemia
Because such patients may benefit from preventive
measures and need to be followed-up closely at fre-
quent intervals to detect and deal with the develop-
ment of manifestations of critical limb ischaemia,
there is a need to identify and characterise a group
of patients with very low perfusion pressures and
therefore high risk, but who may be asymptomatic
and not have claudication because of restricted
activity, nor do they have critical limb ischaemia as
defined in Recommendation 73.
D 1.2
Prognosis
The section on Epidemiology (A 2.7, P 521) details the
various prognostic indicators for loss of limb or death
in patients with CLI. In general, the prognosis is dire
and very much worse than that of patients with inter-
mittent claudication. It is impossible to describe the
natural history of these patients, because almost all
patients diagnosed with CLI will, quite appropriately,
be considered for active treatment, usually some form
of revascularisation, The minority of CLI patients
treated conservatively are in no way representative of
the whole group. They will tend to represent either the
worst end of the spectrum, where no form of revascu-
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larisation is technically possible, or revascularisation
has been tried and failed, or the best end of the CLI
spectrum, with mild rest pain or ulcers without severe
persistent rest pain.
There is, however, information on what happens to
an unselected group of patients newly diagnosed with
CLI and receiving the currently available standard
therapy. In general, such information suggests that a
year after the onset of CLI, only about half the patients
will be alive without a major amputation, although
some of these may still have rest pain, gangrene, or
ulcers (see A 2.7, Epidemiology, p 521; A 2.8, P 521).
Approximately 25% will have died, and 25% will have
required a major amputation. Again, in contrast to
patients with intermittent claudication, patients with
CLI are on a rapidly downward course in terms of
both life and limb, and current noninterventional
treatment or pharmacotherapy can help only a minor-
ity. Hence the increased focus on developing new sur-
gical, endovascular, and pharmacological approaches
to the management of this small, but very seriously ill,
group of patients. Their prognosis is in many ways
similar to that of some malignant forms of cancer.
01.3
Microcirculatory Pathophysiology in eLI
Although pathophysiology is not a primary topic in
this Consensus document, understanding of the gen-
eral pathophysiologic changes in CLI is essential to
optimal management of these patients. Unfortunately,
the precise pathophysiology of CLI in humans
remains to be established. Current knowledge is based
largely on epidemiology in relation to risk factors,
direct measurements in patients, and extrapolation of
results from animal and in vitro studies.s The macro-
circulatory defect is atherosclerosis. Deterioration in
the macrocirculation and the perfusion pressure to the
limb results from gradual increase in the atherosclero-
'sis, with more sudden episodes of deterioration
caused by superimposed thrombosis. Local thrombo-
sis may be the result of the activation of platelets and
leukocytes as they come into contact with ulcerated or
ruptured atherosclerotic plaques, possibly accompa-
nied by downregulations in local anti-thrombotic
defense mechanisms. The special case of patients with
diabetes is discussed in The Diabetic Foot (01. 4, P
5148).
CLI occurs when arterial stenoses or occlusions
impair blood flow to such an extent that despite com-
pensatory mechanisms such as collateral formation,
the nutritive requirements of the peripheral microcir-
culation cannot be met. This is usually caused by multi-
level disease." In some cases, the haemodynamic con-
sequences of arterial lesions may be compounded by
chronic venous insufficiency or decreased cardiac out-
put.
A number of newer techniques have improved the
understanding of the skin microcirculation, which is
the pathological target tissue in most CLI patients.
These include capillaroscopy,'? fluorescence video-
microscopy, 10,11 laser Doppler fluxmetry'" and TCP02
measurements.J3 In contrast to the early stages of PAD,
in which compromised skeletal muscle blood flow
causes intermittent claudication, rest pain and trophic
changes associated with CLI are predominantly attrib-
utable to a critical reduction in skin microcirculation. L
The skin microcirculation is unusual in many ways,
most notably that nutritional capillary blood flow only
represents approximately 15% of the normal total
blood flow in the foot, the remainder having a thermo-
regulatory function only. 10
The normal function of the skin microcirculation
can be considered under two headings: a complex
microvascular flow regulatory system and a series of
defense mechanisms. The microvascular flow-regulat-
ing system includes extrinsic neurogenic mechanisms,
intrinsic local mediators, and modulation by circulat-
ing humoral and blood-borne factors. The endotheli-
um also participates in the regulation of flow by the
release of vasodilatory mediators such as prostacyclin
and endothelium-derived relaxing factor nitric oxide
and several endothelium-derived contractile factors
(eg, endothelin). In addition to the microvascular
flow-regulating system, there are several microvascu-
lar defence mechanisms. The inappropriate activation
of haemostasis and inflammation also playa central
role in the pathophysiology of CLI. In CLI, there is a
maldistribution of the skin microcirculation in addi-
tion to a reduction in total blood flow. The importance
of the local microcirculatory response in individual
patients with CLI is suggested by the wide overlap in
ankle or toe blood pressure, which assess the macro-
circulation, in patients with and without CLI.
Capillary microscopy studies have confirmed an
inhomogeneous distribution of skin microcirculatory
flow. This is accompanied by a reduction in TCP02.13
The final sequence of events leading to decreased cap-
illary perfusion in CLI is not established. Possible con-
tributory causes are collapse of precapillary arterioles
caused by low transmural pressure, arteriolar
vasospasm, abnormal vasomotion, microthromboses,
collapse of capillaries caused by interstitial oedema,
capillary occlusion from endothelial cell swelling,
platelet aggregates, rigid adhesive leukocytes, or
blood cells/platelet aggregates.'! Activation of
platelets and leukocytes and damage of vascular
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endothelium may result in VICIOUS cycles between
these inappropriately activated cells through a num-
ber of mediators.
A variety of markers of blood coagulation have been
detected in conjunction with PAD. These may favour
fibrin formation as well as alterations in blood fibri-
nolytic potential, which may inhibit fibrin dissolution,
for example, high levels 'of plasminogen activator
inhibitor. There is also increasing evidence that leuko-
cytes play an important role in ischaemic disease.P
Activated leukocytes are abnormally rigid and there-
fore candidates for microvascular occlusion. Finally, in
the presence of local infections, it is probable that the
above mechanisms are amplified and compounded by
the release of bacteria-derived toxins from the cellular
and immunological response.w Although hypothetical
because they are mainly extrapolated from animal and
in vitro studies, two mediators, namely EDRF (nitric
oxide) and prostacyclin, may be particularly impor-
tant in deactivating the inappropriately activated cells
and reestablishing flow. Besides its vasodilatory prop-
erties, EDRF inhibits platelet activation synergistically
with prostacyclin."
In summary, although PAD is the underlying and
principal defect in patients with CLI, the low tissue
perfusion pressure sets up a number of complex local
microcirculatory responses, which are the ultimate
cause of the rest pain and trophic changes. Many of
these processes can be viewed as an inapprop riate
response of the microcirculatory flow regulatory
mechanism and its normal defence mechanisms. The
result is a series of auto-multiplying vicious cycles.
Therefore, although the primary aim of treatment
must be the correction of the PAD, attempts to manip-
ulate and normalise the microcirculatory changes
pharmacologically may enhance the results of revas-
cularization and may be the best option in patients in
whom revascularisation is impossible or has failed.
D 1.4
The Diabetic Foot
The management of gangrene or ulcers in diabetic
patients is more difficult than in nondiabetic patients,
as evidenced by the many times greater need for major
amputation for predominant ischaemic disease in the
former compared with the latter (see A 2.9, Major
Amputation, p 522). Eighty-five percent of diabetes
related lower-extremity amputations are preceded by
a foot ulcer. The management of the diabetic with CLI
also illustrates particularly well the need for a multi-
disciplinary approach to the treatment of CLI patients
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in general. There are reports claiming that a multidis-
ciplinary approach, including prevention, patient edu-
cation, and multifactorial treatment of foot ulcers
reduces amputation rate by 43% to 85%.18
Diabetes is an important risk factor for the develop-
ment of atherosclerosis, which becomes clinically
manifest 5 to 10 times more commonly in diabetic
patients than in nondiabetic patients.'? There is gener-
al agreement that diabetic atherosclerosis is more dif-
fuse, more severe, and manifests itself at an earlier age
than atherosclerosis in nondiabetic patients.20,21 The
significance of diabetic microangiopathy, that is, addi-
tional arteriolar and capillary disease, is more contro-
versial. The problem of the diabetic foot is complicat-
ed by the frequent coexistence of diabetic neuropathy,
which can involve sensory, motor, and autonomic
nerve fibres. As a consequence of reduced sensation of
pain and temperature, diabetic patients with sensory
neuropathy may not be able to notice environmental
thermal changes, pressure from poorly fitting shoes,
and other trauma.s- This will predispose to ulceration,
gangrene, and infection (see also D 4.2:2, Foot Care in
Patients With Critical Limb Ischaemia, p 5165).
Motor nerve defects and limited joint mobility may
cause foot deformities, pressure points further predis-
posing to foot lesions. Local consequences of auto-
nomic abnormalities include loss of sweating, dry fis-
sured skin, and increased arteriovenous shunting.
Poorly controlled diabetic patients are more prone to
infection than those who are well controlled. Bacterial
growth is reported to be inhibited by lactic acid, but in
the presence of diabetic ketoacidosis, this inhibition of
bacterial growth is reduced. Finally, the immune sys-
tem is also altered in diabetic patients and antibody
function may be modified as a result of glycosylation
(see also Recommendation 23).
D 1.5
Management Plan
Prompt and appropriate referral
All patients with ulcers, gangrene, or pain in the foot
possibly attributable to PAD should be considered an
urgent case. The leisurely investigation of these
patients in a nonspecialised primary care setting is
quite inappropriate. They should be referred prompt-
ly to a vascular specialist centre with expertise in treat-
ing patients with CLI. This should include availability
of all the specialist services that may be required for
the complete characterisation and subsequent treat-
ment of these difficult cases. Failure to do so prompt-
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ly may increase the patient's risk of losing a leg. It is,
however, an unfortunate fact that many patients with
CLI are still investigated and treated in nonspecialised
centers.
Recommendation 75: Prompt referral of patients
with critical1imb ischaemia
Prompt referral of patients with critical limb
ischaemia to a vascular specialist will improve the
chances of successful treatment.
Ivutliidisciplinan] team approach
Because patients with CLI are likely to have overt or
subclinical multisystem disease, a multidisciplinary
team approach would seem sensible for the diagnosis,
assessment, and treatment of these patients, requiring
the services of a wide variety of specialists. The con-
flicting interests of different single specialties cannot
be in the best interest of the patient. It is therefore one
of the purposes of this consensus document to obtain
multidisciplinary agreement on broad aspects of
patient management.
Recommendation 76: Multidisciplinary approach
in critical1imb ischaemia
Close cooperation between disciplines is particu-
larly desirable for the timely diagnosis and treat-
ment of both diabetic and nondiabetic patients
with critical1imb ischaemia.
Establishing the diagnosis
This is discussed in detail in Evaluation (0 2. 2, P
5152). The first step is to establish whether the patien-
tis disease is predominantly caused by PAD and to
what degree the presenting problem is compounded
by other pathologies such as venous thrombosis, dia-
betic neuropathy, or cardiac failure. Alternative causes
of foot pain or ulcers should be excluded (see
Differential Diagnosis, 0 2. 3, P 5157). The urgency of
the case should be individually assessed, because this
will have a bearing on more detailed investigations. In
general, patients with rest pain alone pose less of an
urgent problem than patients with trophic changes.
The principal cause for great urgency is the coexis-
tence of locally spreading or systemic infection and a
possible recent thrombotic role in the patho-
physiology.
Detailed assessment
This is discussed in detail in Evaluation (0 2. 2, P
5152). The two principal aims of further investigation
of these patients is to delineate the precise anatomy of
the arterial disease and the detection and quantifica-
tion of coexisting disease in other systems. Imaging of
the full arterial supply to the legs is crucial in virtual-
ly all cases of CLI.
Treatment plan
This is discussed in detail in Treatment (0 4, P 5163).
The treatment plan for CLI, as well as any coexisting
disease, is best formulated by discussion between rel-
evant specialists. This is accepted as best practice in
most specialised vascular centres dealing with CLI.
The progress of treatment should be regularly
reviewed, again preferably by a multidisciplinary
team.
Folloto-up
Patients with CLI may be successfully treated in terms
of resolution of the rest pain and healing of trophic
skin changes, but they are never completely or perma-
nently cured. The underlying PAD will continue to
progress, even if its rate of progression may be slowed
down. Recurrence of CLI is common. All such patients
should therefore be regularly followed-up, again
preferably in a specialised centre. It is important to
consider a surveillance program for patients who have
had revascularisation procedures, because this
undoubtedly improves secondary and assisted pri-
mary patency and limb survival (see 0 4.14,
Surveillance, p 5214).
Audit
Follow-up is also essential to obtain complete audit
data. Treatment decisions must be based on the results
obtained in the centre concerned. Too often in the past,
decisions about the risks and benefits of a particular
treatment were based on published data, which is
sometimes incomplete, sometimes based on a differ-
ent patient population, and sometimes obtained by
practitioners with a level of skill that cannot be repro-
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duced in other centres. Alternatively, publications
may be based on outdated studies that do not reflect
improvements in systemic and local care, diagnostic
refinements, and new drugs and interventional tech-
nology. It is therefore essential that each specialised
centre should audit its own results, to set its stan-
dards, judge its level of expertise, and influence ongo-
ing decisions about patient management.
Recommendation 77: Audit in critical limb
ischaemia
It is recommended that all units dealing with criti-
cal limb ischaemia should maintain accurate, audit-
ed records for all patients treated and their
progress. The minimum follow-up analysis should
be in terms of J-year re-interventions, re-admis-
sions, amputation rates, mortality, and, ideally,
other outcome measures.
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02
EVALUATION
02.1
Clinical Evaluation of Critical Limb Ischaemia
D 2.1.1
History
The history of critical arterial insufficiency is domi-
nated by pain; in most cases, the pain is severe, often
intolerable, and it only responds to strong analgesics
or opiates. The pain is caused by ischaemia, areas of
tissue loss, ischaemic neuropathy, or a combination
of these; it occurs or worsens with reduction of per-
fusion pressure. In most cases, walking capacity is
very severely impaired, often becoming almost
impossible. In rare cases, there also may be foot clau-
dication.
Ischaernic rest pain most typically occurs at night
but can occur even during the day when the patient
is resting in supine position. The pain is localised in
the distal part of the foot or in the vicinity of an
ischaemic ulcer or gangrenous toe. The pain is often
